© 2002 by European Society of Cardiology
PACING
High incidence of Pellethane 90A lead malfunction
State University of New York Health Sciences Center at Stony Brook, Department of Medicine Division of Cardiology U.S.A.
Manuscript submitted 15 May 2001. Accepted after revision 14 October 2001.
Correspondence: Roman T. Pachulski, MD, FACC, Director of Arrhythmia Services and Electrophysiology Laboratory, Health Sciences Center T-17-020, SUNY Stony Brook, Stony Brook, New York 11794-8171, U.S.A. E-mail: roman01866{at}aol.com
Key Words: Pellethane 90A, pacemaker leads, insulation malfunction
| Aims |
|---|
|
|
|---|
The long-term performance of Pellethane 80A (P80A) endocardial pacing leads has previously been called into question. We report our experience with an endocardial pacemaker lead with silicone outer and Pellethane 2363-90A (P90) inner insulator.
| Methods |
|---|
|
|
|---|
Between November 1993 and March 1998, 129 P90A and 189 non-P90A ventricular leads were implanted. Lead malfunction was defined as
25% deviation in lead impedance or a two-fold reduction in sensing threshold during follow-up. Sensing and capture thresholds and lead impedance were assessed intraoperatively, immediately postoperatively, at 24 h and 612 weeks following implant and semiannually thereafter. Adequacy of lead positioning and lead-header interface were documented radiographically in each case. | Results |
|---|
|
|
|---|
During 204 patient years of follow-up, 10/129 (8%) Oscor RX P90A leads malfunctioned. Average time to malfunction was 14±11 months. During 166 patient years of follow-up, none of the 189 non-P90A ventricular leads met criteria for malfunction (P< 0·05). There was no difference in patient age, sex, and arrhythmia indication between groups. Sensing problems were overcome with pacemaker reprogramming.
| Conclusion |
|---|
|
|
|---|
We conclude that Oscor RX passive fixation ventricular leads with external silicone and inner P90A insulation exhibit an 8% insulation malfunction rate within 14±11 months of implant. This is significantly higher than non-P90A leads implanted with identical technique and follow-up regimen. More frequent follow up may be warranted in patients with P90A containing leads.
| References |
|---|
|
|
|---|
[1] Antonelli D, Rosenfeld T, Freedberg NA, Palma E, Gross JN, Furman S. Insulation lead malfunction: is it a matter of insulation coating, venous approach, or both? Pacing Clin Electrophysiol 1998; 21: 418421.[CrossRef][Medline]
[2] Hanson JS. Sixteen malfunctions in a single model of bipolar Pellethane-insulated ventricular pacing lead: a 44-month experience. Pacing Clin Electrophysiol 1984; 7: 389394.[Medline]
[3] Hayes DL, Holmes DR Jr, Merideth J, Osborn MJ, Vlietstra RE, Neubauer SA. Bipolar tined Pellethane ventricular lead: a four-year experience. Pacing Clin Electrophysiol 1985; 8: 192196.[Medline]
[4] Hayes DL, Graham KJ, Irwin M, et al. A multicenter experience with a bipolar tined Pellethane ventricular lead. Pacing Clin Electrophysiol 1992; 15: 10331039.[Medline]
[5] Hayes DL, Graham KJ, Irwin M, et al. Multicenter experience with a bipolar tined Pellethane ventricular lead. Pacing Clin Electrophysiol 1995; 18: 9991004.[CrossRef][Medline]
[6] Levander-Lindgren M. A 20-year study of endocardial pacing lead EMT 588. Lead durability and nature of malfunction. Scand J Thorac Cardiovasc Surg 1988; 22: 16.[Medline]
[7] Furman S, Benedek ZM, Andrews CA, Gross JN, Ritacco R. Long-term follow-up of pacemaker lead systems: establishment of standards of quality. Pacing Clin Electrophysiol 1995; 18: 271285.[Medline]
[8] Stokes KB and Church T. Ten-year experience with implanted Pellethane lead insulation. Pacing Clin Electrophysiol 1986; 9: 11601165.[Medline]
[9] Sethi KK, Pandit N, Bhargava M., Mohan JC, Arora R, Khalilullah M. Long term performance of silicone insulated and pellethane insulated cardiac pacing leads. Indian Heart J 1992; 44: 145149.[Medline]
[10] Stokes K, Cobian K, Lathrop T, et al. Pellethane insulators, a design approach to small pacing leads. In Meere C (Ed.). Cardiac Pacing: State of the Art 1979; .
[11] Phillips R, Frey M, Martin RO. Long-term performance of pellethane pacing leads: mechanisms of design-related malfunctions. Pacing Clin Electrophysiol 1986; 9: 11661172.[Medline]
[12] Sharif MN, Wyse DG, Rothschild JM, Gillis AM. Changes in pacing lead impedance over time predict lead malfunction. Am J Cardiol 1998; 82: 600603.[CrossRef][Medline]
[13] Beyersdorf F, Kreuzer J, Schmidts L, Satter P. Examination of explanted Pellethane pacemaker leads using the scanning electron microscope. Pacing Clin Electrophysiol 1985; 8: 562568.[Medline]
[14] Byrd CL, Schwartz SJ, Sivian M, et al. In degradation of pellethane endocardial pacing leads: An 8-year retrospective analysis. In Plank H, Syre I, Dauner M (Eds.), et al. Pellethane in Biomedical Engineering II 1987; Amsterdam Elsevier Publishing.
[15] Stokes KB, Urbanski PW, Cobian K. New test methods for the evaluation of stress cracking and metal catalyzed oxidation in implanted polymers. II International Conference, Pellethanes in Biomedical Engineering, Amsterdam, Elsevier.
[16] Danilovic D and Ohm OJ. Pacing impedance variability in tined steroid eluting leads. Pacing Clin Electrophysiol 1998; 21: 13561363.[Medline]
[17] Physician's Manual: Endotak Endurance Rx Models 0144/0145/0146. St Paul, Cardiac Pacemakers, Inc. 1999.
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||